Zevra Therapeutics (ZVRA) Receivables - Other (2015 - 2024)
Zevra Therapeutics (ZVRA) posted Receivables - Other of $333000.0 for Q4 2024, down 73.53% on a QoQ basis from $1.3 million in Q4 2023, and down 73.53% year-over-year from $1.3 million in Q1 2024.
Zevra Therapeutics (ZVRA) Receivables - Other (2015 - 2024) Analysis & Trends
Zevra Therapeutics' Receivables - Other history runs 10 years deep, the most recent figure standing at $333000.0 for Q4 2024.
- Quarterly Receivables - Other fell 73.53% year-over-year to $333000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $333000.0 (down 73.53% YoY) and the FY2024 annual result came in at $333000.0, down 73.53% from the prior year.
- Receivables - Other was $333000.0 for Q4 2024 at Zevra Therapeutics, down from $1.3 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.3 million in Q4 2023 and bottomed at $107000.0 in Q4 2021.
- A 5-year average of $543625.0 and a median of $366500.0 in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other jumped 941.12% — and 2024, when it tumbled 73.53%.
- Zevra Therapeutics' Receivables - Other stood at $137000.0 in 2020, then declined by 21.9% to $107000.0 in 2021, then soared by 941.12% to $1.1 million in 2022, then gained by 12.93% to $1.3 million in 2023, then tumbled by 73.53% to $333000.0 in 2024.
- Business Quant data shows ZVRA's Receivables - Other at $333000.0 in Q4 2024, $1.3 million in Q4 2023, and $700000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 333,000.00 |
| Dec 31, 2024 | 333,000.00 |
| Dec 31, 2023 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Mar 31, 2023 | 700,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 1.11 Mn |
| Dec 31, 2022 | 1.11 Mn |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Dec 31, 2021 | 107,000.00 |
| Dec 31, 2021 | 107,000.00 |
| Dec 31, 2020 | 137,000.00 |
| Dec 31, 2020 | 137,000.00 |
| Dec 31, 2019 | 184,000.00 |
| Dec 31, 2019 | 184,000.00 |
| Dec 31, 2018 | 140,000.00 |
| Dec 31, 2018 | 140,000.00 |